This is a preview of subscription content, log in via an institution to check access.
Reference
Le P, et al. Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50 Years. Annals of Internal Medicine : 8 Sep 2015. Available from: URL: http://dx.doi.org/10.7326/M15-0093
Rights and permissions
About this article
Cite this article
Poor value of herpes zoster vaccine at aged 50 in the US. PharmacoEcon Outcomes News 737, 25 (2015). https://doi.org/10.1007/s40274-015-2471-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2471-5